STE STERIS Earnings and EPS analysis

Relative Growth: Rel. Growth: 94

Relative Strength: Rel. Strength: 22

Relative Valuation: Rel. Valuation: 62

Relative Profitability: Rel. Profitability: 76

EPS in 2026 (TTM): $7.97

Last Report Period Date: Mar 31, 2026

According to the most recent financial data from March 2026, the current EPS (TTM) is $7.97. STERIS's EPS for 2026 came in at $7.97, marking an increase from $6.24 in 2025. For the quarterly period ending on Mar 31, 2026, STE's EPS was $2.25.

STE earnings history

Historical annual and quarterly earnings per share (EPS) data for STERIS

EPS (TTM)

$7.97

EPS Growth YoY (Quarterly)

51%

EPS (Quarterly)

$2.25

EPS Growth (Quarterly)

14.8%

STERIS had an annual EPS of $7.97, marking an increase of 27.7% from $6.24 in 2025. The quarterly EPS for the period ending Mar 31, 2026, was $2.25, marking a 51% increase from the same quarter last year. STE's TTM EPS stands at $7.97 as of March 2026. STERIS's EPS for 2025 stood at $6.24, a 62.9% increase from 2024.

STE earnings chart

STE EPS growth history

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

51%

EPS growth YoY

27.7%

EPS growth 3Y avg

95.3%

EPS growth 5Y avg

11.3%

Over the last 12 months, STERIS has registered an EPS growth of 51% (YoY, quarterly). Over a three-year span, the company had an average EPS growth of 95.3% per year. Over the last 5 years, the company had an average EPS growth rate of 11.3%. When measured over a ten-year period, STE's average EPS growth rate was 17.6%.

STE Earnings Waterfall

Breakdown of revenue, profit and net income for STERIS

STE Earnings vs Peers

What are the earnings of STE compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
KMB Kimberly Clark Corp	16.32	-19.7%	2.1%	-2.5%
CNMD CONMED Corp	19.08	-64.6%	N/A	35.7%
STE STERIS plc	25.5	27.7%	95.3%	11.3%
TMO Thermo Fisher Scientific Inc	25.75	7.2%	0%	2%
JNJ Johnson & Johnson	27.39	90.6%	17.7%	14.8%
MMM 3M Co	31	-20.2%	-16%	-8.5%
SYK Stryker Corp	35.47	8%	10.9%	14.8%
ECL Ecolab Inc	36.11	-1.3%	24.2%	N/A
ACH Accendra Health Inc.	N/A	-202.5%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.